Citigroup Inc Corcept Therapeutics Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Citigroup Inc holds 144,706 shares of CORT stock, worth $7.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

144,706

Previous 96,436 50.05%

Holding current value

$7.44 Million

Previous $3.13 Million 113.66%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$29.51 - $46.26 $1.42 Million - $2.23 Million	48,270 Added 50.05%	144,706 $6.69 Million
Q2 2024 Aug 12, 2024	SELL	$22.21 - $34.48 $233,538 - $362,557	-10,515 Reduced 9.83%	96,436 $3.13 Million
Q1 2024 May 10, 2024	BUY	$21.1 - $27.46 $592,466 - $771,049	28,079 Added 35.6%	106,951 $2.69 Million
Q4 2023 Feb 09, 2024	BUY	$24.82 - $32.88 $671,480 - $889,535	27,054 Added 52.21%	78,872 $2.56 Million
Q3 2023 Nov 09, 2023	SELL	$21.97 - $33.8 $771,498 - $1.19 Million	-35,116 Reduced 40.39%	51,818 $1.41 Million
Q2 2023 Aug 10, 2023	BUY	$21.44 - $25.15 $305,477 - $358,337	14,248 Added 19.6%	86,934 $1.93 Million
Q1 2023 May 11, 2023	SELL	$19.2 - $24.47 $39,782 - $50,701	-2,072 Reduced 2.77%	72,686 $1.57 Million
Q4 2022 Feb 09, 2023	BUY	$19.95 - $29.96 $76,268 - $114,537	3,823 Added 5.39%	74,758 $1.52 Million
Q3 2022 Nov 10, 2022	BUY	$24.7 - $29.12 $53,549 - $63,132	2,168 Added 3.15%	70,935 $1.82 Million
Q2 2022 Aug 10, 2022	SELL	$17.33 - $25.3 $597,434 - $872,192	-34,474 Reduced 33.39%	68,767 $1.64 Million
Q1 2022 May 12, 2022	BUY	$16.53 - $25.21 $222,956 - $340,032	13,488 Added 15.03%	103,241 $2.33 Million
Q4 2021 Feb 10, 2022	BUY	$17.1 - $23.34 $40,971 - $55,922	2,396 Added 2.74%	89,753 $1.78 Million
Q3 2021 Nov 10, 2021	BUY	$19.68 - $22.53 $1.72 Million - $1.97 Million	87,357 New	87,357 $1.72 Million

Others Institutions Holding CORT

# of Institutions

346

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.51B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account